Speedy bug ID: new tests aim to cut antibiotic guesswork in ICU blood infections

NCT ID NCT05741424

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether three new diagnostic tools could help doctors pick the best antibiotic faster for ICU patients with Gram-negative bloodstream infections. Researchers compared standard lab methods to the new tests in 100 patients. The goal was to see if more patients got the right, narrowest antibiotic within 24 hours of a blood sample.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Diagnostic tests (BacT/Alert VIRTUO, BioFire BCID2, REVEAL)
What this could lead to: If successful, this could show that using these advanced tests helps doctors pick the most effective antibiotic sooner, potentially improving patient outcomes in the ICU.
What could go wrong: This is a small, single-center study with only 100 patients, so results may not apply to all hospitals. The tests themselves don't treat the infection—they only guide treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTEREMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis gram-negative bacterial infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTEREMIA

Contacts and locations

Locations

CHU de Nîmes

Nîmes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.